Technischer Ausbruch:
Diese Kupferaktie ist in den letzten 52 Wochen um 300 % gestiegen!
Anzeige
DYNAVAX WKN: A12EV9 ISIN: US2681582019 Kürzel: DVAX Forum: Aktien Thema: Hauptdiskussion
10,87 EUR
+0,09 %+0,01
2. Nov, 12:58:52 Uhr,
Lang & Schwarz
Kommentare 2.275
Summer.76,
6. Aug 22:48 Uhr
0
https://www.prnewswire.com/news-releases/dynavax-reports-second-quarter-2024-financial-results-and-provides-business-updates-302215762.html
Summer.76,
08.05.2024 23:57 Uhr
1
https://www.prnewswire.com/news-releases/dynavax-reports-first-quarter-2024-financial-results-and-provides-business-updates-302140240.html
B
Bigge,
11.04.2024 22:33 Uhr
0
Sehr ruhig hier.
Summer.76,
22.02.2024 22:24 Uhr
1
https://www.prnewswire.com/news-releases/dynavax-reports-fourth-quarter-and-full-year-2023-financial-results-and-provides-full-year-2024-financial-guidance-302068488.html
Dynavax Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Financial Guidance
Summer.76,
02.11.2023 21:41 Uhr
1
Dynavax Reports Third Quarter 2023 Financial Results and Raises Full Year Revenue Guidance
https://www.prnewswire.com/news-releases/dynavax-reports-third-quarter-2023-financial-results-and-raises-full-year-revenue-guidance-301975340.html
H
Hanntz,
08.08.2023 20:16 Uhr
0
Was passierte hier am kurs gestern und heute sieht es ähnlich aus?
Summer.76,
03.08.2023 22:21 Uhr
0
Dynavax Reports Second Quarter 2023 Financial Results and Raises Full Year Revenue Guidance
https://www.prnewswire.com/news-releases/dynavax-reports-second-quarter-2023-financial-results-and-raises-full-year-revenue-guidance-301892494.html
• Generated record quarterly HEPLISAV-B® vaccine net product revenue of $56 million, a 73% year-over-year increase
• Full year HEPLISAV-B net product revenue guidance raised to $200 - $215 million, compared to prior range of $165 - $185 million
• Cash and investments increased to $682 million at quarter end; expects positive free cash flow for full year
Summer.76,
23.05.2023 18:54 Uhr
0
Ich hatte jetzt auch nichts anderes gefunden. Da war - vorhin jedenfalls - schon bissel Bewegung im 'Bio-Markt'.
Das Volumen hier ist aber nicht besonders auffällig bisher.
Hanntz,
23.05.2023 17:45 Uhr
0
Obwohl ich sehe gerade, dass generell die impfbuden heute zwischen 5 und 9 Prozent liegen... 🙄
H
Hanntz,
23.05.2023 17:43 Uhr
0
@Summer.76, weißt du was wegen dem Anstieg heute? Good rumors vor der HV oder nur blinde Spekulation?
Summer.76,
03.05.2023 6:46 Uhr
0
Dynavax misses on bottom line, but reaffirms 2023 guidance
https://seekingalpha.com/news/3964031-dynavax-misses-bottom-line-reaafirms-2023-guidance
• Although its Q1 2023 bottom line results came in below expectations, Dynavax Technologies (NASDAQ:DVAX) is trading flat in after-hours trading.
• The boost could be the result of a sigh of relief from investors as the company maintained its 2023 financial guidance. This included projected HEPLISAV-B product revenue of between $165M and $185M.
• In the quarter, Dynavax (DVAX) swung to a net loss ~$24.3M from net income of ~$32.9M in the year-ago period (-$0.19 per share diluted vs. $0.32).
• The company was hurt in the quarter by a 59% decline in revenue to ~$46.9M.
• Dynavax (DVAX) recorded no CpG 1018 adjuvant product revenue in Q1, compared to $91.5M in Q1 2022 as the company finished its obligations and product delivery under adjuvant COVID-19 collaboration agreements.
• The company ended the quarter with cash, cash equivalents, and marketable securities of ~$652M, a ~4% increase from Dec. 31, 2022.
Summer.76,
03.05.2023 6:44 Uhr
0
https://beststocks.com/dynavax-technologies-corp-reports-q1-financia/
z
zsclions,
31.03.2023 16:13 Uhr
0
nächste woche grosser impfkonferenz in washington💪🚀
Summer.76,
28.02.2023 16:53 Uhr
1
https://www.prnewswire.com/news-releases/dynavax-announces-great-britain-marketing-authorization-for-heplisav-b-a-two-dose-adult-hepatitis-b-adjuvanted-vaccine-301757659.html
Dynavax Announces Great Britain Marketing Authorization for HEPLISAV B®, a Two-Dose Adult Hepatitis B Adjuvanted Vaccine
Summer.76,
23.02.2023 22:09 Uhr
1
Dynavax Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Full Year 2023 Financial Guidance
https://investors.dynavax.com/news-releases/news-release-details/dynavax-reports-fourth-quarter-and-full-year-2022-financial
Summer.76,
01.02.2023 6:08 Uhr
1
Dynavax Announces Uplisting to the Nasdaq Global Select Market
https://www.prnewswire.com/news-releases/dynavax-announces-uplisting-to-the-nasdaq-global-select-market-301734858.html
...today announced that effective as of market open today, January 31, 2023, its common stock has been approved for uplisting to the Nasdaq Global Select Market® and will continue trading under its current ticker symbol "DVAX". ...
Meistdiskutiert
|
Thema | ||
---|---|---|---|
1 | BORUSSIA DORTMUND Hauptdiskussion | ±0,00 % | |
2 | BIOXCEL THERAPEUT DL-,001 Hauptdiskussion | ±0,00 % | |
3 | MicroStrategy | +0,09 % | |
4 | BED BATH & BEYOND Hauptdiskussion | ±0,00 % | |
5 | Trading- und Aktien-Chat | ||
6 | BTC/USD Hauptdiskussion | +0,47 % | |
7 | VW Hauptdiskussion | ±0,00 % | |
8 | Hyzon Motors Registered (A) Hauptdiskussion | -0,57 % | |
9 | GAMESTOP Hauptdiskussion | -0,05 % | |
10 | NVIDIA Hauptdiskussion | +0,36 % | Alle Diskussionen |
Aktien
|
Thema | ||
---|---|---|---|
1 | BORUSSIA DORTMUND Hauptdiskussion | ±0,00 % | |
2 | BIOXCEL THERAPEUT DL-,001 Hauptdiskussion | ±0,00 % | |
3 | MicroStrategy | +0,09 % | |
4 | BED BATH & BEYOND Hauptdiskussion | ±0,00 % | |
5 | VW Hauptdiskussion | ±0,00 % | |
6 | GAMESTOP Hauptdiskussion | -0,05 % | |
7 | NVIDIA Hauptdiskussion | +0,36 % | |
8 | Nio für normale Kommunikation | ±0,00 % | |
9 | VALNEVA SE Hauptdiskussion | ±0,00 % | |
10 | Gamestop💎🙌 | -0,05 % | Alle Diskussionen |